Posted inGenetics
Posted inGenetics
The State of Cell and Gene Therapy 2025
Broadcast Date: Wednesday, January 29, 2025Time: 8:00 am PT, 11:00 am ET, 17:00 CET The field of cell and gene…
Posted inBiotechnology
Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’
Alphabet spinoff SandboxAQ has raised more than $300 million to go toward developing AI applications across multiple areas including drug…
Posted inBiotechnology
Lawsuit accuses Applied Therapeutics of misleading investors before FDA rejection
After its rare disease drug was rejected by the FDA in late November, Applied Therapeutics vowed to fight on with…
Posted inBiotechnology
Editor’s Corner: Fierce Biotech’s 10 most-read stories of 2024
For the end of this year, Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting.…
Posted inGenetics
Deep Learning Slashes Cell Line Development Time
A biopharma company specializing in difficult-to-produce biologics has developed a deep learning model to rapidly predict protein expression using their…
Posted inGenetics
Optimizing TFF for mRNA Filtration
As steadily increasing numbers of mRNA vaccines and therapeutics advance through clinical trials and commercialization, the biopharmaceutical industry is pressed…
Posted inGenetics
Starting Material Determines Cell-Based Product Quality
Recently, Charles River Laboratories—a provider of products and services for drug research and development—presented a webinar about starting material for…
Posted inGenetics
DNA-Based Vaccine Production Provides Best Shot at Profitability
Messenger RNA-based vaccine production has become a major industry focus, thanks to the success of jabs developed during the pandemic.…
Posted inResearch
Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids
Through its U.S. and Canada life science business MilliporeSigma, Merck KGaA is acquiring Dutch company HUB Organoids. The deal is…
Posted inBiotechnology
Ring Therapeutics lays off just under half of staff in 2nd wave of cuts this year, CEO set to step down
Ring Therapeutics, a Flagship Pioneering-backed biotech developing new viral vectors for gene therapy delivery, has cut its staff by just…